Kowa - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsKowa

Kowa

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Livalo	Pitavastatin	2009-08-03	2024-2031	Hypercholesterolemia , Hypertriglyceridemia , Hyperlipoproteinemias
Seglentis	Celecoxib, Tramadol	2021-10-15	2029-2038	Ankylosing spondylitis , Rheumatoid arthritis , Osteoarthritis , Adenomatous polyposis coli , Dysmenorrhea , Hypertension , Coronary artery disease , Variant angina pectoris , Pain

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

drug interactions

,

myeloid leukemia acute

,

,

b-cell chronic lymphocytic leukemia

,

human influenza

,

,

,

,

,

,

,

,

breast neoplasms

,

hyperlipoproteinemia type ii

,

,

,

,

,

hypercholesterolemia

,

hyperlipidemias

,

,

healthy volunteers/patients

,

diabetes mellitus

,

cardiovascular diseases

,

coronary disease

,

,

hyperlipoproteinemias

,

acute coronary syndrome

,

metabolic syndrome

,

myocardial infarction

,

coronary artery disease

,

myocardial ischemia

,

,

renal insufficiency

,

type 2 diabetes mellitus

,

kidney diseases

,

,

inferior wall myocardial infarction

,

,

,

chronic renal insufficiency

,

angina pectoris

,

atherosclerosis

,

oxidative stress

,

glucose intolerance

,

prediabetic state

,

heart disease risk factors

,

,

percutaneous coronary intervention

,

,

glucose metabolism disorders

,

metabolic diseases

,

liver transplantation

,

immunosuppression therapy

,

drug-related side effects and adverse reactions

,

malignant hyperthermia

,

metabolic bone diseases

,

,

postmenopausal osteoporosis

,

vascular calcification

,

,

preconception care

,

alzheimer disease

,

insulin resistance

,

non-alcoholic fatty liver disease

,

,

hypersensitivity

,

,

atherosclerotic plaque

,

carotid artery diseases

,

,

benign paroxysmal positional vertigo

,

,

bronchopulmonary dysplasia

,

retinopathy of prematurity

,

hereditary angioedemas

,

,

gaucher disease

,

ulcerative colitis

,

,

liver cirrhosis

,

,

,

biliary liver cirrhosis

,

non-alcoholic fatty liver disease

,

,

,

diabetic retinopathy

,

type 2 diabetes mellitus

,

hyperlipidemias

,

hypercholesterolemia

,

,

healthy volunteers/patients

,

type 2 diabetes mellitus

,

non-alcoholic fatty liver disease

renal insufficiency

,

type 2 diabetes mellitus

Tofogliflozin anhydrous

healthy volunteers/patients

,

type 2 diabetes mellitus

,

colorectal neoplasms

,

retinal diseases

,

kidney diseases

,

chronic renal insufficiency

,

type 2 diabetes mellitus

,

diabetes mellitus

,

chronic kidney failure

,

,

renal insufficiency

,

,

chronic hepatitis c

,

,

hypercholesterolemia

,

hypercholesterolemia

,

,

atopic dermatitis

,

,

,

prostatic neoplasms

1

2

>

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use